Happy 100th Birthday American Cancer Society

05.24.13 | By

When President Nixon signed the National Cancer Act of 1971, there were three million cancer survivors. Today, there are more than 13 million. By 2022, this number will increase to 18 million.

Bob Hugin’s Call to Action: Protect Medical Innovation

05.23.13 | By

Bob Hugin, Chairman and CEO, Celgene and Chairman of the PhRMA Board, recently sat down with Life Science Leader magazine to talk about the value of medical innovation.  If you haven’t read it already, I urge you to do so because Bob offers some very insightful thoughts on why we as a society should celebrate biopharmaceutical in

Report Highlights Importance of Intellectual Property Protections

05.23.13 | By

With TPP, Indian and other IP infringement and innovation issues shaping international headlines in recent weeks, IP is increasingly being recognized as a central driver of growth, development and access to medicines. A report released today by the Commission on the Theft of American Intellectual Property reinforces IP's critical importance: hundreds of billions of dollars and thousands of U.S.

STEM Education and Future Innovators in America

05.22.13 | By

Did you know that fewer than 40 percent of students who enter college intending to major in a STEM (science, technology, engineering and math) field actually graduate with a STEM degree?

This is very troubling.

Rick Smith Testified Before Congress Today About Why Part D Works

05.22.13 | By

PhRMA’s Rick Smith, Executive Vice President of Policy and Research, testified today in a hearing called, “10 Years Later: A Look at the Medicare Prescription Drug Program,” hosted by the Senate’s Special Committee on Aging.

Protecting IP: Balancing Current and Future Interests

05.22.13 | By

With the 17th round of Trans-Pacific Partnership negotiations taking place in Lima, Peru, the importance of strong U.S. trade and innovation policy is once again front and center. When it comes to protecting intellectual property, it’s critical that negotiators keep in mind the far-reaching implications of pro-IP measures on our economy, health and well being, and society overall.

Research in Your Backyard May Soon Be in Latin America

05.22.13 | By

In Colombia, unprecedented price controls in the private market are being contemplated and such policies – a threat to continued research and development of new medicines – are already in effect in El Salvador and also under consideration elsewhere in the region. 

Far too often in Latin America, we’re smeared with the negative “Big Pharma” label and too many policymakers have the perception that we don’t have a very positive impact in their countries.

RxOpen Activated to Report on Status of Pharmacies in Oklahoma

WASHINGTON, D.C. (May 20, 2013) – Rx Response  elevated its status to Alert and has activated Rx Open in the aftermath of yesterday’s deadly tornado in Moore, Oklahoma. (www.RxResponse.org).  Rx Response and Rx Open are initiatives of America’s bio-pharmaceutical supply system to help ensure the continued flow of medicine to patients in a severe public health emergency,

New Study is Latest Proof That Part D Helps Save Money While Improving Health

05.21.13 | By

This past weekend the American Journal of Managed Care released a study titled, “The Economic Impact of Medicare Part D on Congestive Heart Failure.”

Key findings of study include:

Uplifting Athletes: Raising Awareness, Patients’ Spirits and Funds for Research

05.20.13 | By

Uplifting Athletes is a nonprofit organization that works with college football players to raise awareness of rare disease, raise funds for research and support individual rare disease patients.  The chapters are run by student athletes at universities across the country.  Their work recently gained national attention when the

Pages

Subscribe to RSS - Opinion